LakeShore Biopharma Co., Ltd. (LSBCF) › Operating IncomeLakeShore Biopharma Co., Ltd. (LSBCF) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2021: -125.85M CNY2022: -118.96M CNY2023: -139.38M CNY2024: -445.83M CNY2025: -86.29M CNY-86.29M CNY2021Operating Income (CNY)2025Fiscal YearOperating IncomeChange YoY2025-86.29M CNY+80.6%2024-445.83M CNY-219.9%2023-139.38M CNY-17.2%2022-118.96M CNY+5.5%2021-125.85M CNY—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share